GlassScriptPhysician profile
David Seamont
NPI 1083148274
$4,352.74
in general payments reported to CMS, 2019-2025
17 companies · $1,308 in 2025
The $1,308 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $413 · 2023: $922 · 2024: $1,561 · 2025: $1,308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,791.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,305.87 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Alcon Vision LLC | $1,107.39 | 2022-2025 | Clareon, Simbrinza, Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $418.70 | 2022-2025 | Tecnis Iol, Tecnis Iol |
| New World Medical,INC. | $310.27 | 2022-2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Glaukos Corporation | $264.38 | 2021-2025 | Idosetr |
| Bausch & Lomb Americas INC. | $237.20 | 2022-2024 | Envista Mx60 Iol, Vyzulta, Stellaris |
| Thea Pharma INC. | $167.98 | 2022-2024 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $162.52 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $120.55 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Mallinckrodt Hospital Products INC. | $65.46 | 2022-2024 | Acthar |
| Harrow Eye, LLC | $52.04 | 2025 | Vevye |
| Amgen INC. | $34.71 | 2025 | Tepezza |
| Astellas Pharma US INC | $24.41 | 2025 | Izervay |
| Ani Pharmaceuticals, INC. | $22.42 | 2024 | Purified Cortrophin Gel |
| Dompe US, INC. | $20.16 | 2025 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $19.79 | 2021 | |
| Allergan, INC. | $18.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Seamont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.